BMO Capital Maintains Outperform on Nutrien, Raises Price Target to $90

Benzinga Newsdesk www.benzinga.com Positive 90.3%

Neg 0% Neu 0% Pos 90.3%

BMO Capital analyst Joel Jackson maintains Nutrien (NYSE:NTR) with a Outperform and raises the price target from $85 to $90.